242 related articles for article (PubMed ID: 31695780)
1. Orally Deliverable Nanotherapeutics for the Synergistic Treatment of Colitis-Associated Colorectal Cancer.
Han W; Xie B; Li Y; Shi L; Wan J; Chen X; Wang H
Theranostics; 2019; 9(24):7458-7473. PubMed ID: 31695780
[No Abstract] [Full Text] [Related]
2. Berberine regulates short-chain fatty acid metabolism and alleviates the colitis-associated colorectal tumorigenesis through remodeling intestinal flora.
Yan S; Chang J; Hao X; Liu J; Tan X; Geng Z; Wang Z
Phytomedicine; 2022 Jul; 102():154217. PubMed ID: 35660350
[TBL] [Abstract][Full Text] [Related]
3. Vitexin prevents colitis-associated carcinogenesis in mice through regulating macrophage polarization.
Chen Y; Wang B; Yuan X; Lu Y; Hu J; Gao J; Lin J; Liang J; Hou S; Chen S
Phytomedicine; 2021 Mar; 83():153489. PubMed ID: 33571919
[TBL] [Abstract][Full Text] [Related]
4. Expression of the novel adipokine C1qTNF-related protein 4 (CTRP4) suppresses colitis and colitis-associated colorectal cancer in mice.
Luo Y; Wu X; Ma Z; Tan W; Wang L; Na D; Zhang G; Yin A; Huang H; Xia D; Zhang Y; Shi X; Wang L
Cell Mol Immunol; 2016 Sep; 13(5):688-99. PubMed ID: 27086950
[TBL] [Abstract][Full Text] [Related]
5. Suppression of colitis-associated carcinogenesis through modulation of IL-6/STAT3 pathway by balsalazide and VSL#3.
Do EJ; Hwang SW; Kim SY; Ryu YM; Cho EA; Chung EJ; Park S; Lee HJ; Byeon JS; Ye BD; Yang DH; Park SH; Yang SK; Kim JH; Myung SJ
J Gastroenterol Hepatol; 2016 Aug; 31(8):1453-61. PubMed ID: 26711554
[TBL] [Abstract][Full Text] [Related]
6. An efficient enzyme-triggered controlled release system for colon-targeted oral delivery to combat dextran sodium sulfate (DSS)-induced colitis in mice.
Li S; Jin M; Wu Y; Jung S; Li D; He N; Lee MS
Drug Deliv; 2021 Dec; 28(1):1120-1131. PubMed ID: 34121560
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
[TBL] [Abstract][Full Text] [Related]
8. Single probiotic supplement suppresses colitis-associated colorectal tumorigenesis by modulating inflammatory development and microbial homeostasis.
Rong J; Liu S; Hu C; Liu C
J Gastroenterol Hepatol; 2019 Jul; 34(7):1182-1192. PubMed ID: 30357910
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory natural product goniothalamin reduces colitis-associated and sporadic colorectal tumorigenesis.
Vendramini-Costa DB; Francescone R; Posocco D; Hou V; Dmitrieva O; Hensley H; de Carvalho JE; Pilli RA; Grivennikov SI
Carcinogenesis; 2017 Jan; 38(1):51-63. PubMed ID: 27797827
[TBL] [Abstract][Full Text] [Related]
10. Identification of Novel Core Genes Involved in Malignant Transformation of Inflamed Colon Tissue Using a Computational Biology Approach and Verification in Murine Models.
Markov AV; Savin IA; Zenkova MA; Sen'kova AV
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901742
[TBL] [Abstract][Full Text] [Related]
11. Oral Targeted Delivery by Nanoparticles Enhances Efficacy of an Hsp90 Inhibitor by Reducing Systemic Exposure in Murine Models of Colitis and Colitis-Associated Cancer.
Yang M; Zhang F; Yang C; Wang L; Sung J; Garg P; Zhang M; Merlin D
J Crohns Colitis; 2020 Jan; 14(1):130-141. PubMed ID: 31168612
[TBL] [Abstract][Full Text] [Related]
12. Effect of particle size on the cellular uptake and anti-inflammatory activity of oral nanotherapeutics.
Zhou X; Liu Y; Wang X; Li X; Xiao B
Colloids Surf B Biointerfaces; 2020 Mar; 187():110880. PubMed ID: 32098717
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effect of hydroxychloroquine on colorectal carcinogenesis in experimental murine colitis.
Yao J; Xie J; Xie B; Li Y; Jiang L; Sui X; Zhou X; Pan H; Han W
Biochem Pharmacol; 2016 Sep; 115():51-63. PubMed ID: 27288548
[TBL] [Abstract][Full Text] [Related]
14. Activation of the mTORC1 and STAT3 pathways promotes the malignant transformation of colitis in mice.
He Z; He X; Chen Z; Ke J; He X; Yuan R; Cai Z; Chen X; Wu X; Lan P
Oncol Rep; 2014 Nov; 32(5):1873-80. PubMed ID: 25174408
[TBL] [Abstract][Full Text] [Related]
15. DNA damage response genes mark the early transition from colitis to neoplasia in colitis-associated colon cancer.
Sharp SP; Malizia RA; Walrath T; D'Souza SS; Booth CJ; Kartchner BJ; Lee EC; Stain SC; O'Connor W
Gene; 2018 Nov; 677():299-307. PubMed ID: 30121380
[TBL] [Abstract][Full Text] [Related]
16. RIP3 promotes colitis-associated colorectal cancer by controlling tumor cell proliferation and CXCL1-induced immune suppression.
Liu ZY; Zheng M; Li YM; Fan XY; Wang JC; Li ZC; Yang HJ; Yu JM; Cui J; Jiang JL; Tang J; Chen ZN
Theranostics; 2019; 9(12):3659-3673. PubMed ID: 31281505
[No Abstract] [Full Text] [Related]
17. Inhibition of TLR4 Signaling Impedes Tumor Growth in Colitis-Associated Colon Cancer.
Pastille E; Faßnacht T; Adamczyk A; Ngo Thi Phuong N; Buer J; Westendorf AM
Front Immunol; 2021; 12():669747. PubMed ID: 34025672
[TBL] [Abstract][Full Text] [Related]
18. GPR65 (TDAG8) inhibits intestinal inflammation and colitis-associated colorectal cancer development in experimental mouse models.
Marie MA; Sanderlin EJ; Satturwar S; Hong H; Lertpiriyapong K; Donthi D; Yang LV
Biochim Biophys Acta Mol Basis Dis; 2022 Jan; 1868(1):166288. PubMed ID: 34628032
[TBL] [Abstract][Full Text] [Related]
19. Natural shikonin and acetyl-shikonin improve intestinal microbial and protein composition to alleviate colitis-associated colorectal cancer.
Lin H; Ma X; Yang X; Chen Q; Wen Z; Yang M; Fu J; Yin T; Lu G; Qi J; Han H; Yang Y
Int Immunopharmacol; 2022 Oct; 111():109097. PubMed ID: 35952517
[TBL] [Abstract][Full Text] [Related]
20. Clerodane Diterpene Ameliorates Inflammatory Bowel Disease and Potentiates Cell Apoptosis of Colorectal Cancer.
Zheng JH; Lin SR; Tseng FJ; Tsai MJ; Lue SI; Chia YC; Woon M; Fu YS; Weng CF
Biomolecules; 2019 Nov; 9(12):. PubMed ID: 31766534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
